Cargando…
Probiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial [ISRCTN38327949]
BACKGROUND: Infectious complications are the major cause of death in acute pancreatitis. Small bowel bacterial overgrowth and subsequent bacterial translocation are held responsible for the vast majority of these infections. Goal of this study is to determine whether selected probiotics are capable...
Autores principales: | Besselink, Marc GH, Timmerman, Harro M, Buskens, Erik, Nieuwenhuijs, Vincent B, Akkermans, Louis MA, Gooszen, Hein G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC526218/ https://www.ncbi.nlm.nih.gov/pubmed/15456517 http://dx.doi.org/10.1186/1471-2482-4-12 |
Ejemplares similares
-
Minimally invasive 'step-up approach' versus maximal necrosectomy in patients with acute necrotising pancreatitis (PANTER trial): design and rationale of a randomised controlled multicenter trial [ISRCTN38327949]
por: Besselink, Marc GH, et al.
Publicado: (2006) -
Probiotics Prevent Intestinal Barrier Dysfunction in Acute Pancreatitis in Rats via Induction of Ileal Mucosal Glutathione Biosynthesis
por: Lutgendorff, Femke, et al.
Publicado: (2009) -
Prophylactic antibiotic for prevention of posttraumatic meningitis after traumatic pneumocephalus: design and rationale of a placebo-controlled randomized multicenter trial [ISRCTN71132784]
por: Eftekhar, Behzad, et al.
Publicado: (2006) -
Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]
por: Ostadal, Petr, et al.
Publicado: (2005) -
Pancreatitis, very early compared with normal start of enteral feeding (PYTHON trial): design and rationale of a randomised controlled multicenter trial
por: Bakker, Olaf J, et al.
Publicado: (2011)